Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $49,873 - $56,568
-759 Reduced 19.12%
3,211 $222,000
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $1 - $614
8 Added 0.2%
3,970 $283,000
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $2,520 - $3,022
-41 Reduced 1.02%
3,962 $291,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $536 - $625
-10 Reduced 0.25%
4,003 $248,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $18,046 - $21,139
-305 Reduced 7.06%
4,013 $237,000
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $185 - $202
3 Added 0.07%
4,318 $288,000
Q1 2021

May 28, 2021

SELL
$59.34 - $66.74 $118 - $133
-2 Reduced 0.05%
4,315 $273,000
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $230 - $261
-4 Reduced 0.09%
4,317 $268,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $6,891 - $7,636
-120 Reduced 2.7%
4,321 $259,000
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $4,111 - $4,806
-75 Reduced 1.66%
4,441 $261,000
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $4,640 - $6,743
-100 Reduced 2.17%
4,516 $253,000
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $227,153 - $296,301
4,616 New
4,616 $297,000
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $170,892 - $212,998
-3,382 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $3,355 - $3,862
-56 Reduced 1.63%
3,382 $216,000
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $299 - $326
-5 Reduced 0.15%
3,438 $212,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $190,156 - $219,456
3,443
3,443 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ssi Investment Management LLC Portfolio

Follow Ssi Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ssi Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ssi Investment Management LLC with notifications on news.